Tony Bishop service user representative Professor Kenneth Muir Professor of Epidemiology University of Manchester Old Trafford 21 September 2017 Greater Manchester Cancer Vanguard Innovation ID: 638125
Download Presentation The PPT/PDF document "Showcase: Patient self-referral" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Showcase:
Patient self-referralTony Bishop, service user representativeProfessor Kenneth Muir, Professor of Epidemiology, University of Manchester
Old Trafford21 September 2017
Greater Manchester
Cancer
Vanguard InnovationSlide2
Housekeeping
There are no scheduled fire drills
We will be taking
photos – please let us know if you don’t want your picture takenThe
presentation will be
online after
the eventPhones on silent, but follow us on Twitter: @GM_Ca_Vanguard
Vanguard Innovation
Greater Manchester
CancerSlide3
The national Cancer Vanguard
Vanguard Innovation
Greater Manchester
Cancer
To develop and test new ideas to deliver more responsive and personalised cancer services, addressing inequalities and supporting the NHS in ‘
Achieving World Class Cancer Outcomes’.
Two-year programme to look at improved cancer care, cancer outcomes, cancer patient experience and resource efficiencySlide4
Vanguard Innovation
Two times cancer patient! Catching the cancer early was vital to the outcome for me
Greater Manchester CancerSlide5
Whose job is it to ‘find’ cancer?
In the 1970s, aged 28, I kept getting a hoarse voice My GP advised throat lozenges, no other investigationsUnhappy with that, I resorted to going to see my company doctor. He took it seriously and did appropriate referralsI was diagnosed with cancer of the larynx.
Vanguard Innovation
Greater Manchester
CancerSlide6
What ifs……
What do you think of my voice? If cancer of the larynx hadn’t been found when it was, my treatment would have had to be more radical, for example to have my voice box removed and I wouldn’t even have the voice I have now! Vanguard Innovation
Greater Manchester
CancerSlide7
Vanguard Innovation
A job for the persistent patient? Greater Manchester Cancer
In 2008, once retired, I was concerned at not getting a routine medical check up, so I took up an offer of a BUPA
health check which included blood tests An examination and the PSA test found prostate
cancer
No screening for prostate cancer even though PSA provides an indicator
Prostate cancer detected early so I've survived with minimal
effects on my lifestyleSlide8
Why am I here?
Vanguard Innovation
Greater Manchester Cancer
Having a voice
speaking up
Being heard Slide9
Importance of early diagnosis: survival
time is more than three times higher when cancer is diagnosed earlyVanguard Innovation
Greater Manchester
Cancer
10 year survival data from East of England 1996-2000 for
eight
major cancers
(bladder
, bowel, breast,
cervical
,
womb
,
malignant melanoma, ovarian and testicular )Slide10
Vanguard Innovation
Greater Manchester
Cancer
Question? – show of hands, pleaseHow many of you went to a travel agent to choose/book your last holiday?
How many of you used the internet to choose/book your last holiday?Slide11
The aim
of this program of work is to derive an effective and cost-effective way to increase the direct referral for timely investigation of patients with potentially indicative cancer symptoms and thereby reduce delays in receiving a definitive diagnosis or discharge.To do this we will perform within the current cancer Vanguard funding envelope a one-year pilot with the following objectives:To
develop a risk-based approach to direct symptom-based referral from the community.
To widen access to community-based engagement opportunities to pilot the model.
To
assess
users’ views and experiences of using the approach.
Vanguard Innovation
Greater Manchester
CancerSlide12
Current Pathway
Vanguard Innovation
Greater Manchester CancerSlide13
Proposed Pathway Enhancement
Vanguard Innovation
Greater Manchester CancerSlide14
Vanguard Innovation
Greater Manchester
Cancer
Does it work? Slide15
Vanguard Innovation
Greater Manchester
Cancer
Yin/Yang
Prevention/Early detectionSlide16
Vanguard Innovation
Greater Manchester
Cancer
REFLECT –Manchester websiteSlide17
Vanguard Innovation
Greater Manchester
CancerSlide18
Vanguard Innovation
Greater Manchester
Cancer
AcknowledgementsSlide19
Thank you
More information on the User Involvement Programme, including Vanguard projectsgmcancer.org.uk/our-areas-of-work/user-involvement Follow us on Twitter @GMCancerUIVanguard Innovation
Greater Manchester
CancerSlide20
Vanguard Innovation
Greater Manchester CancerSlide21
Panel
Vanguard Innovation
Greater Manchester Cancer
Professor Ken Muir, Professor of Epidemiology, University of
Manchester
Tony Bishop, Service User
Representative
Marzena Nieroda, Lecturer in Marketing, University of Manchester
Dr Artitaya Lophatananon, Research Fellow, University of
ManchesterJames Clark, Programme Manager, Greater Manchester Cancer Vanguard InnovationSlide22
Vanguard Innovation
Greater Manchester
Cancer
Greater Manchester Cancer
Vanguard
Innovation
Email
:
cancervanguard.gm.@nhs.net
Web
:
gmcancervanguardinnovation.org
Twitter
: @GM_Ca_Vanguard